quantit
pcr
method
establish
quantifi
human
bocaviru
hbov
genom
copi
clinic
specimen
children
lower
respiratori
tract
infect
lrti
china
total
respiratori
tract
specimen
test
sputum
sampl
posit
genom
copi
rang
sampl
main
clinic
symptom
patient
posit
hbov
dna
pneumonialik
syndrom
repres
high
fever
cough
result
suggest
hbov
may
import
etiolog
agent
lrti
children
china
find
viru
infect
major
caus
lower
respiratori
tract
infect
lrti
children
worldwid
import
viral
agent
arguabl
respiratori
syncyti
viru
rsv
other
virus
influenza
virus
parainfluenza
virus
adenovirus
rhinovirus
coronavirus
human
metapneumoviru
also
frequent
report
caus
lrti
human
bocaviru
hbov
first
clone
pool
human
respiratori
tract
sampl
collect
sweden
provision
classifi
genu
bocaviru
base
sequenc
comparison
hbov
report
worldwid
present
respiratori
sampl
test
individu
acut
respiratori
ill
appear
associ
ltri
date
studi
report
detect
hbov
dna
children
lrti
china
current
detect
hbov
children
lrti
mainli
reli
dna
amplif
regular
pcr
assay
quantit
posit
result
hard
interpret
recent
reliabl
quantit
pcr
qpcr
method
develop
detect
hbov
genom
copi
clinic
sampl
demonstr
presenc
hbov
dna
children
pneumonialik
symptom
thailand
studi
use
qpcr
amplicon
target
ns
code
region
hbov
detect
presenc
hbov
dna
children
respiratori
tract
infect
china
result
suggest
hbov
may
import
etiolog
agent
lrti
children
china
total
specimen
collect
decemb
februari
infant
children
lrti
hospit
wenl
first
hospit
zhejiang
provinc
china
specimen
includ
throat
swab
nasopharyng
aspir
sputum
aspir
sputum
togeth
blood
sampl
day
hospit
blood
sampl
test
neg
antibodi
direct
influenza
viru
b
respiratori
syncyti
viru
rsv
parainfluenza
viru
adenoviru
commerci
avail
elisa
kit
clinic
sampl
taken
inform
consent
obtain
parent
legal
guardian
dna
extract
clinic
specimen
perform
follow
throat
swab
nasopharyng
aspir
dilut
ml
pb
centrifug
rpm
min
pellet
resuspend
pb
sputum
aspir
sputum
specimen
digest
volum
naoh
centrifug
rpm
min
pellet
wash
pb
resuspend
final
volum
pb
resuspend
pellet
extract
dna
use
qiaamp
blood
mini
kit
qiagen
plasmid
pskhbov
contain
hbov
sequenc
nt
synthes
extens
pcr
fragment
primer
design
base
sequenc
hbov
genbank
subsequ
insert
pbluescript
vector
stratagen
plasmid
use
control
genom
copi
establish
standard
curv
absolut
quantif
use
taqman
technolog
appli
biosystem
system
foster
citi
calif
quantit
pcr
method
amplicon
taqman
probe
hbov
specif
quantit
pcr
design
primer
express
softwar
appli
biosystem
conserv
region
ns
code
region
among
hbov
genom
sequenc
deposit
genbank
sequenc
follow
forward
primer
agc
ttt
tgt
tga
ttc
aag
gct
ata
atc
hbov
nt
revers
primer
tgt
ttc
ccg
aat
tgt
ttg
ttc
hbov
nt
probe
agc
cgt
tgg
tca
cgc
cct
hbov
nt
taqman
univers
pcr
master
mix
appli
biosystem
use
amplif
standard
protocol
extract
dna
use
reaction
volum
hbov
dna
detect
sputum
aspir
sputum
total
specimen
test
posit
hbov
qpcr
tabl
posit
sampl
either
sputum
aspir
sputum
indic
signific
presenc
hbov
dna
lower
respiratori
tract
signific
age
differ
detect
hbov
genom
specimen
posit
sampl
contain
substanti
titer
viru
genom
copi
rang
ml
origin
collect
sampl
ml
suggest
activ
replic
viru
lower
respiratori
tract
main
clinic
symptom
patient
posit
hbov
dna
pneumonialik
syndrom
repres
high
fever
cough
rate
detect
observ
popul
lower
averag
previous
report
might
reflect
either
truli
lower
frequenc
hbov
infect
zhejiang
provinc
china
altern
variat
amplicon
within
chines
hbov
isol
addit
lower
copi
number
viral
genom
detect
assay
perhap
limit
extract
dna
specimen
inhibitor
qpcr
clinic
specimen
investig
differ
pair
primer
probe
quantifi
hbov
genom
clinic
sampl
way
probe
etiolog
hbov
ltri
children
use
addit
normal
control
nevertheless
quantit
pcr
method
provid
reliabl
mean
screen
sampl
high
titer
genom
copi
viru
isol
begin
address
relationship
hbov
lrti
children
china
hbov
human
bocaviru
ltri
lower
respiratori
tract
infect
qpcr
quantit
polymeras
chain
reaction
